The concept of active sites is fundamental in the field of drug discovery, as it plays a crucial role in understanding how drugs interact with their target proteins. 

What are active sites? 

An active site is a specific region on enzymes or receptors where substrates bind to perform or elicit and produce a biologic response. The ways the sites are structured and the characteristics of these sites determine the efficacy and specificity of potential drug candidates. (Cooper GM, 2000). They are types of active sites; Catalytic sites, allosteric sites, regulatory sites etc.

In drug discovery, the active site identification of a target protein is essential for designing effective inhibitors or activators. That is for preparing effective substrates that'll cause an inhibiting effect or activating biological response. (Tabana, et al 2023.) The active site is made up of a specific arrangement of amino acids that create a specific three-dimensional shape, allowing certain molecules to bind effectively. The selectivity of an active site is vital for the development of drugs that can help modulate biological pathways without causing noticeable off-target effects. (Robinson et al, 2015).

In a case of certain enzyme inhibitors, the drug must fit properly into the active site to block the enzyme's function, hence preventing the conversion of substrates into products.

The process of identifying active sites often involves techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational modeling. These processes/ techniques/ methods allow researchers to visualize the structure of the target protein and its active site, providing a better understanding into how different molecules can interact with it. (Mueller et al, 2013) After the site has been characterized, insightfully observed, medicinal chemists can design small molecules that mimic the natural substrates or ligands, optimizing their properties to enhance binding affinity and specificity. (Ekins et al, 2007). In understanding the dynamics of active sites, a crucial context of drug resistance is understood For example, mutations in the active site can lead to reduced binding of the drug, making it less effective. This phenomenon is commonly seen in cancer therapy cases, where tumor cells may develop resistance to targeted treatments. (Mansoori et al 2017) 

Ongoing research into the active sites of target proteins is necessary to develop next-generation drugs that can circumvent resistance mechanisms.

To round up, the concept of active sites is bedrock or can be said to be a strong base in drug discovery, influencing the design and development of therapeutic agents. When the structure and functions of active sites are understood, researchers can create more effective and selective drugs, ultimately improving patient outcomes. As technology advances, the ability to identify and manipulate active sites will continue to enhance the field of pharmacology and medicine paving the way for innovative treatments for various diseases

AUTHOR: OkaEwa Faith I.

REFERENCES

.1. Berg, J. M., Tymoczko, J. L., & Stryer, L. (2012). \*Biochemistry\*. W\.H. Freeman.

.2. Fersht, A. R. (1999). \*Structure and Mechanism in Protein Science\*. W\.H. Freeman.

.3. Gorre, M. E., et al. (2001). "Clinical Resistance to STI571 Cancer Therapy Caused by BCR-ABL Gene Mutations." \*Science\*, 293(5531), 876-880.

.4. Schmidt, J. J., et al. (2017). "Structural Insights into Protein-Protein Interactions: The Role of Active Sites." \*Current Opinion in Structural Biology\*, 42, 1-8.

REFERENCES

Cooper GM. The Cell: A Molecular Approach. 2nd edition. Sunderland (MA): Sinauer Associates; 2000. The Central Role of Enzymes as Biological Catalysts. Available from: https\://www\.ncbi.nlm.nih.gov/books/NBK9921/

Ekins, S., Mestres, J., & Testa, B. (2007). In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. British journal of pharmacology, 152(1), 9–20. https\://doi.org/10.1038/sj.bjp.0707305

Mansoori, B., Mohammadi, A., Davudian, S., Shirjang, S., & Baradaran, B. (2017). The Different Mechanisms of Cancer Drug Resistance: A Brief Review. Advanced pharmaceutical bulletin, 7(3), 339–348. https\://doi.org/10.15171/apb.2017.041

Mueller, L. J., & Dunn, M. F. (2013). NMR crystallography of enzyme active sites: probing chemically detailed, three-dimensional structure in tryptophan synthase. Accounts of chemical research, 46(9), 2008–2017. https\://doi.org/10.1021/ar3003333

Robinson P. K. (2015). Enzymes: principles and biotechnological applications. Essays in biochemistry, 59,(1)41. https\://doi.org/10.1042/bse0590001

Tabana, Y., Babu, D., Fahlman, R., Siraki, A. G., & Barakat, K. (2023). Target identification of small molecules: an overview of the current applications in drug discovery. BMC biotechnology, 23(1),44. https\://doi.org/10.1186/s12896-023-00815-4

  
